收费全文 | 3802篇 |
免费 | 283篇 |
国内免费 | 19篇 |
耳鼻咽喉 | 26篇 |
儿科学 | 111篇 |
妇产科学 | 101篇 |
基础医学 | 587篇 |
口腔科学 | 136篇 |
临床医学 | 463篇 |
内科学 | 871篇 |
皮肤病学 | 98篇 |
神经病学 | 308篇 |
特种医学 | 86篇 |
外科学 | 397篇 |
综合类 | 19篇 |
一般理论 | 3篇 |
预防医学 | 345篇 |
眼科学 | 22篇 |
药学 | 237篇 |
中国医学 | 11篇 |
肿瘤学 | 283篇 |
2023年 | 45篇 |
2022年 | 65篇 |
2021年 | 142篇 |
2020年 | 87篇 |
2019年 | 102篇 |
2018年 | 141篇 |
2017年 | 114篇 |
2016年 | 114篇 |
2015年 | 122篇 |
2014年 | 141篇 |
2013年 | 199篇 |
2012年 | 257篇 |
2011年 | 238篇 |
2010年 | 148篇 |
2009年 | 131篇 |
2008年 | 181篇 |
2007年 | 221篇 |
2006年 | 219篇 |
2005年 | 219篇 |
2004年 | 170篇 |
2003年 | 141篇 |
2002年 | 106篇 |
2001年 | 67篇 |
2000年 | 63篇 |
1999年 | 57篇 |
1998年 | 32篇 |
1997年 | 39篇 |
1996年 | 15篇 |
1995年 | 29篇 |
1994年 | 25篇 |
1993年 | 14篇 |
1992年 | 29篇 |
1991年 | 27篇 |
1990年 | 40篇 |
1989年 | 29篇 |
1988年 | 33篇 |
1987年 | 17篇 |
1986年 | 21篇 |
1985年 | 29篇 |
1984年 | 22篇 |
1983年 | 15篇 |
1979年 | 12篇 |
1977年 | 12篇 |
1975年 | 12篇 |
1974年 | 10篇 |
1973年 | 17篇 |
1972年 | 15篇 |
1971年 | 10篇 |
1970年 | 14篇 |
1968年 | 10篇 |
Objective
To review the published literature on the performance of indirect immunofluorescence (IIF)–HEp‐2 antinuclear antibody (ANA) testing for classification of systemic lupus erythematosus (SLE).Methods
A systematic literature search was conducted in the Medline, Embase, and Cochrane databases for articles published between January 1990 and October 2015. The research question was structured according to Population, Intervention, Comparator, Outcome (PICO) format rules, and Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) recommendations were followed where appropriate. Meta‐regression analysis for diagnostic tests was performed, using the ANA titer as independent variable, while sensitivity and specificity were dependent variables.Results
Of 4,483 publications screened, 62 matched the eligibility criteria, and another 2 articles were identified through reference analysis. The included studies comprised 13,080 SLE patients in total, of whom 12,542 (95.9%) were reported to be IIF‐ANA positive at various titers. For ANA at titers of 1:40, 1:80, 1:160, and 1:320, meta‐regression gave sensitivity values of 98.4% (95% confidence interval [95% CI] 97.6–99.0%), 97.8% (95% CI 96.8–98.5%), 95.8% (95% CI 94.1–97.1%), and 86.0% (95% CI 77.0–91.9%), respectively. The corresponding specificities were 66.9% (95% CI 57.8–74.9%), 74.7% (95% CI 66.7–81.3%), 86.2% (95% CI 80.4–90.5%), and 96.6% (95% CI 93.9–98.1%), respectively.Conclusion
The results of this systematic literature review and meta‐regression confirm that IIF‐ANAs have high sensitivity for SLE. ANAs at a titer of 1:80 have sufficiently high sensitivity to be considered as an entry criterion for SLE classification criteria, i.e., formally test other classification criteria for SLE only if ANAs of at least 1:80 have been found.Control or gestational low-protein diet perinatal rat pancreas was harvested at embryonic day 20 (E20), day of birth (P0) and postnatal day 2 (P2). TFF3 mRNA was upregulated 4.5-fold at P0 vs. E20 and downregulated again at P2. In protein-undernourished pups induction of TFF3 at P0 was further increased to 9.7-fold and was increased at P2. TFF3 caused tyrosine phosphorylation of EGFR in INS-1E β-cells, and purified recombinant TFF3 increased both attachment and spreading of INS-1E β-cells. In ex vivo cultures of collagenase digested fetal rat pancreas, a model of perinatal β-cell maturation, TFF3 increased cellular spreading as well as insulin mRNA levels. TFF3 also increased the expression of Pref1/Dlk1 that shares similarities in expression and regulation with TFF3.
These results suggest that TFF3 may promote adhesion and spreading of cells to accelerate β-cell maturation. This study indicates a functional role for TFF3 in pancreatic β-cell maturation in the perinatal period, which is altered by low protein diet during gestation. 相似文献